Demonstrating value and ensuring compliance is a priority – and more challenging than ever
Healthcare systems across the globe are evolving as expenses rise alongside improvements in care, and the need to control costs becomes paramount. Payers are increasingly demanding proof of value from new medicines, raising the bar for compliance policies and requiring more evidence of patient impact. For today’s drug developers, the emphasis has shifted from “time to market” to “time to access.”
What is a Medical Science Liaison?
Medical Science Liaisons (MSLs) are therapeutic specialists with advanced scientific training. They are experts in communicating complex scientific and medical information to a variety of stakeholders. The primary role of an MSL is to build and maintain strong relationships with KOLs in their shared therapeutic category, e.g. oncology, CNS, cardiovascular, etc. In addition, MSLs can gather insights to help inform business strategy, i.e. market access and product development.
MSLs are proving increasingly important to help support clinical product positioning well before launch. The role of MSL both complements and exceeds that of traditional sales representatives. As therapeutic specialists – many of whom have PharmD and PhD degrees – Quintiles MSLs possess the deeper expertise and experience required to effectively engage key opinion leaders (KOLs), payers, clinicians and other important stakeholders in your target markets.
By clearly communicating a strategic and cohesive value message to key stakeholders, the path to market access can be navigated more effectively and efficiently.
- Discover how Medical Science Liaisons (MSLs) can be an integral part of your team and gain a deeper insight into:
- The difference between a traditional sales representative and a MSL
- How MSLs can help to prepare the market during the pre-launch phase
- Effectively engaging with key opinion leaders (KOLs) and stakeholders
- Best practice and key success factors for in-the-field MSLs.